Should I buy or sell 908 Devices stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MASS shares. View MASS analyst ratings or view top-rated stocks .

What is 908 Devices' stock price target for 2024?

1 Wall Street analysts have issued 1 year price objectives for 908 Devices' shares. Their MASS share price targets range from $14.00 to $14.00. On average, they expect the company's share price to reach $14.00 in the next year. This suggests a possible upside of 150.4% from the stock's current price. View analysts price targets for MASS or view top-rated stocks among Wall Street analysts .

How have MASS shares performed in 2024?

908 Devices' stock was trading at $11.22 at the start of the year. Since then, MASS shares have decreased by 50.2% and is now trading at $5.59. View the best growth stocks for 2024 here .

When is 908 Devices' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our MASS earnings forecast .

How were 908 Devices' earnings last quarter?

908 Devices Inc. (NASDAQ:MASS) issued its quarterly earnings data on Tuesday, March, 5th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.03. The firm had revenue of $14.40 million for the quarter, compared to analyst estimates of $14.16 million. 908 Devices had a negative trailing twelve-month return on equity of 21.09% and a negative net margin of 72.47%. The firm's quarterly revenue was up 24.1% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.31) EPS.

What ETFs hold 908 Devices' stock?

ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include ARK Genomic Revolution ETF (ARKG) . Alger 35 ETF (ATFV) .

What guidance has 908 Devices issued on next quarter's earnings?

908 Devices updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $52.0 million-$54.0 million, compared to the consensus revenue estimate of $55.5 million.

When did 908 Devices IPO?

908 Devices (MASS) raised $101 million in an initial public offering on Friday, December 18th 2020. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair acted as the underwriters for the IPO.

How do I buy shares of 908 Devices?

Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:MASS

908 Devices (MASS) Stock Price, News & Analysis

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Free MASS Stock Alerts

$5.59

-0.20 (-3.45%)

(As of 04/17/2024 ET)

Compare

Today's Range: $5.50
▼
$5.99
50-Day Range: $5.59
▼
$7.72
52-Week Range: $4.85
▼
$12.51

Volume: 167,634 shs
Average Volume: 170,472 shs
Market Capitalization: $183.97 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $14.00

Get 908 Devices alerts:

908 Devices MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 150.4% Upside
$14.00 Price Target
Short Interest: Bearish
4.84% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$139,955 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($1.29) to ($1.17) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.37 out of 5 stars

Medical Sector

481st out of 914 stocks

Measuring & Controlling Devices, Not Elsewhere Classified Industry

7th out of 10 stocks

3.5

Analyst's Opinion

Consensus Rating
908 Devices has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
908 Devices has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.84% of the float of 908 Devices has been sold short.
Short Interest Ratio / Days to Cover
908 Devices has a short interest ratio ("days to cover") of 6.9.
Change versus previous month
Short interest in 908 Devices has recently increased by 9.52%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
908 Devices does not currently pay a dividend.
Dividend Growth
908 Devices does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MASS.

1.3

News and Social Media Coverage

News Sentiment
908 Devices has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

4.2

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, 908 Devices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $139,955.00 in company stock.
Percentage Held by Insiders
27.80% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for 908 Devices are expected to grow in the coming year, from ($1.29) to ($1.17) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of 908 Devices is -4.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of 908 Devices is -4.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
908 Devices has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

About 908 Devices Stock (NASDAQ:MASS)

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

MASS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MASS Stock News Headlines

March 28, 2024 | msn.com

The drug users being given phones to rebuild their lives

March 16, 2024 | finance.yahoo.com

MASS Apr 2024 7.500 call

April 17, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

March 14, 2024 | msn.com

China responds to TikTok ban: 'This will inevitably backfire on the U.S.'

March 12, 2024 | businesswire.com

908 Devices Trace Chemical Identification Technology Adopted by European Agencies

March 7, 2024 | markets.businessinsider.com

Buy Rating Affirmed for 908 Devices Amidst PAT Growth and Solid Financial Outlook

March 7, 2024 | insidermonkey.com

908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call Transcript

March 5, 2024 | finance.yahoo.com

908 Devices Inc (MASS) Reports Growth Amidst Industry Headwinds

April 17, 2024 | DTI (Ad)

Don’t expose yourself to stocks during the week

March 5, 2024 | businesswire.com

908 Devices Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Revenue Outlook

March 4, 2024 | benzinga.com

908 Devices Earnings Preview

March 4, 2024 | msn.com

908 Devices Q4 2023 Earnings Preview

February 29, 2024 | finance.yahoo.com

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares’ Fully Integrated Cell Therapy Manufacturing Platform

February 29, 2024 | businesswire.com

908 Devices and Cellares Collaborate to Integrate In-line Monitoring of Bioprocess Parameters into the Cell Shuttle, Cellares' Fully Integrated Cell Therapy Manufacturing Platform

February 22, 2024 | finance.yahoo.com

908 Devices to Participate in Upcoming Investor Conferences

February 22, 2024 | businesswire.com

908 Devices to Participate in Upcoming Investor Conferences

February 20, 2024 | finance.yahoo.com

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

February 20, 2024 | businesswire.com

908 Devices to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

February 9, 2024 | finance.yahoo.com

We're Not Very Worried About 908 Devices' (NASDAQ:MASS) Cash Burn Rate

February 3, 2024 | finance.yahoo.com

908 Devices Inc CFO Griffith Joseph H. IV Sells 15,409 Shares

February 2, 2024 | ca.finance.yahoo.com

Just Released: RISMedia's 2024 Real Estate Agent & Broker Marketing Study

February 2, 2024 | msn.com

2024 Rivian R1T Dual-Motor Review: Better Range, Better Value

February 1, 2024 | finance.yahoo.com

908 Devices Inc. (MASS)

January 1, 2024 | ca.finance.yahoo.com

MASS Feb 2024 12.500 put

January 1, 2024 | ca.finance.yahoo.com

MASS Aug 2024 12.500 call

December 28, 2023 | msn.com

908 Devices Inc. (MASS) Upgraded to Buy: What Does It Mean for the Stock?

December 22, 2023 | finance.yahoo.com

Chief Product Officer Christopher Brown Sells 20,000 Shares of 908 Devices Inc

See More Headlines

Receive MASS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 908 Devices and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/05/2024
Today: 4/17/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Measuring & controlling devices, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NASDAQ:MASS
CUSIP: N/A
CIK: 1555279
Web: www.908devices.com
Phone: 857-254-1500
Fax: N/A
Employees: 230
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $14.00
High Stock Price Target: $14.00
Low Stock Price Target: $14.00
Potential Upside/Downside: +145.6%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.13)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-36,400,000.00
Net Margins: -72.47%
Pretax Margin: -72.89%
Return on Equity: -21.09%
Return on Assets: -17.32%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.71
Quick Ratio: 7.04

Sales & Book Value

Annual Sales: $50.23 million
Price / Sales: 3.73
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $5.11 per share
Price / Book: 1.12

Miscellaneous

Outstanding Shares: 32,910,000
Free Float: 23,761,000
Market Cap: $187.59 million
Optionable: Optionable
Beta: 0.93

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Dr. Kevin J. Knopp Ph.D. (Age 51)
Co-Founder, CEO, President & Director
Comp: $788.88k
Dr. Christopher David Brown Ph.D. (Age 49)
Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board
Comp: $459.7k
Mr. Joseph H. Griffith IV (Age 49)
CFO & Treasurer
Comp: $468.98k
Mr. Steve Araiza
Co-Founder
Mr. Andrew Bartfay
Co-Founder & Director of Hardware Development
Mr. Michael Jobin
Co-Founder & Director of Product Development
Dr. Scott Miller Ph.D.
Co-founder & Director of MS Engineering
Mr. Michael S. Turner Esq. (Age 57)
J.D., Chief Legal & Administrative Officer and Secretary
Comp: $97.84k
Mr. Don Osmer (Age 58)
Vice President of Human Resources

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MASS Stock Analysis - Frequently Asked Questions

Should I buy or sell 908 Devices stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for 908 Devices in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MASS shares.
View MASS analyst ratings or view top-rated stocks.
What is 908 Devices' stock price target for 2024?: 1 Wall Street analysts have issued 1 year price objectives for 908 Devices' shares. Their MASS share price targets range from $14.00 to $14.00. On average, they expect the company's share price to reach $14.00 in the next year. This suggests a possible upside of 150.4% from the stock's current price.
View analysts price targets for MASS or view top-rated stocks among Wall Street analysts.
How have MASS shares performed in 2024?: 908 Devices' stock was trading at $11.22 at the start of the year. Since then, MASS shares have decreased by 50.2% and is now trading at $5.59.
View the best growth stocks for 2024 here.
When is 908 Devices' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our MASS earnings forecast.
How were 908 Devices' earnings last quarter?: 908 Devices Inc. (NASDAQ:MASS) issued its quarterly earnings data on Tuesday, March, 5th. The company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.03. The firm had revenue of $14.40 million for the quarter, compared to analyst estimates of $14.16 million. 908 Devices had a negative trailing twelve-month return on equity of 21.09% and a negative net margin of 72.47%. The firm's quarterly revenue was up 24.1% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.31) EPS.

What ETFs hold 908 Devices' stock?: ETFs with the largest weight of 908 Devices (NASDAQ:MASS) stock in their portfolio include ARK Genomic Revolution ETF (ARKG).Alger 35 ETF (ATFV).
What guidance has 908 Devices issued on next quarter's earnings?: 908 Devices updated its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $52.0 million-$54.0 million, compared to the consensus revenue estimate of $55.5 million.
When did 908 Devices IPO?: 908 Devices (MASS) raised $101 million in an initial public offering on Friday, December 18th 2020. The company issued 6,300,000 shares at a price of $15.00-$17.00 per share. Cowen, SVB Leerink, Stifel and William Blair acted as the underwriters for the IPO.
How do I buy shares of 908 Devices?: Shares of MASS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MASS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

908 Devices (MASS) Stock Price, News & Analysis

908 Devices MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

Company Ownership

Earnings and Valuation

About 908 Devices Stock (NASDAQ:MASS)

MASS Stock Price History

MASS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

MASS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™